Biome AustraliaASX:BIO -1.72%35 Days Payable is 122.76 as of Dec. 2025, which is 29% below its 10-year median of 173.72. GuruFocus rates ASX:BIO with a GF Score™ of 35/100 and a GF Value™ of A$0.70 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 1,881 Consumer Packaged Goods companies, Biome Australia ranks better than 91.33% on this metric.
The historical rank and industry rank for Biome Australia's Days Payable or its related term are showing as below:
ASX:BIO'
s Days Payable Range Over the Past 10 Years
Min: 148.88 Med: 173.72 Max: 201.55
Current: 148.88
During the past 5 years, Biome Australia's highest Days Payable was 201.55. The lowest was 148.88. And the median was 173.72.
ASX:BIO's Days Payable is ranked better than 91.33% of 1881
companies
in the Consumer Packaged Goods industry
Industry Median: 44.14
vs ASX:BIO: 148.88
Biome Australia's Days Payable
declined
from Dec. 2024 (170.11) to Dec. 2025 (122.76).
It may suggest that Biome Australiaaccelerated paying its suppliers.
Biome Australia Days Payable Related Terms
Biome Australia Days Payable Historical Data
* Premium members only.
The historical data trend for Biome Australia's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Biome Australia's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biome Australia Days Payable vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Biome Australia's Days Payable distribution charts can be found below:
* The bar in red indicates where Biome Australia's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Biome Australia's Days Payable for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biome Australia (ASX:BIO) has a Days Payable of 122.76 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Biome Australia and its competitors. This is 29% below median its historical median of 173.72. Over the past decade, Biome Australia's Days Payable has ranged from 148.88 to 201.55. According to the industry distribution chart, Biome Australia ranks #163 out of 1881 companies in the Consumer Packaged Goods industry, placing it in the top 8.7%.
Is Biome Australia's Days Payable too high?
Biome Australia's current Days Payable of 122.76 is 29% below median its 10-year median of 173.72. Over the past 10 years, this metric has ranged from a low of 148.88 to a high of 201.55. The Consumer Packaged Goods industry median Days Payable is 44.14. Biome Australia's value of 122.76 is 178.1% above this industry median. Based on the distribution chart, Biome Australia ranks #163 out of 1881 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Biome Australia has a GF Score™ of 35/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Biome Australia's Days Payable compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Biome Australia ranks #163 out of 1881 companies for Days Payable. This places Biome Australia in the top 9% of its industry — outperforming the majority of peers. The industry median Days Payable is 44.14. Biome Australia's value of 122.76 is 178.1% above this benchmark. Historically, Biome Australia's own Days Payable has ranged from 148.88 to 201.55 over the past decade. While the company's 10-year median is 173.72 vs. the industry median of 44.14, Biome Australia has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Consumer Packaged Goods company?
The median Days Payable among Consumer Packaged Goods companies is 44.14, based on 1,881 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Biome Australia's current Days Payable of 122.76 is 178.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Biome Australia and its competitors. For the Consumer Packaged Goods industry, the median Days Payable is 44.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biome Australia's current Days Payable is 122.76, which is 29% below median its own 10-year median of 173.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biome Australia stock overvalued right now?
Based on GuruFocus' analysis, Biome Australia (ASX:BIO) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.70, compared to a current price of A$0.29 — trading 59.3% below its estimated fair value. The current Days Payable is 122.76, which is 29% below median its 10-year median of 173.72 and 178.1% above the Consumer Packaged Goods industry median of 44.14. Biome Australia's overall GF Score™ is 35/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Biome Australia (ASX:BIO), the current Days Payable is 122.76 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Biome Australia (ASX:BIO) Overvalued in 2026?
Based on GuruFocus' analysis, Biome Australia stock appears to be undervalued.
The current stock price of A$0.29 is trading 59.3% below its estimated GF Value™ of A$0.70.
GuruFocus considers Biome Australia to be Possible Value Trap.
Key valuation signals for ASX:BIO:
Days Payable: 122.76 (29% below median its 10-year median of 173.72)
GF Value™: A$0.70 vs. price of A$0.29 (59.3% below fair value)
Industry Position: 178.1% above the Consumer Packaged Goods median (#163 of 1881)
No single metric tells the full story. See the ASX:BIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Biome Australia Ltd licences, develops, and markets evidence-based, complementary medicines, including nutraceuticals vitamins and weight management products and live biotherapeutics. The company has one operating segment: researching, developing, manufacturing and distributing evidence-based products linking the gut and human health. Domestically it caters to Australia and In international markets, the Group distributes and markets its Activated Probiotics range in the United Kingdom and New Zealand through independent health practitioners.
35GF Score
Get the complete analysis for ASX:BIO
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:BIO has been successfully added to your 
